Consensus CVS Health Corporation

Equities

CVS

US1266501006

Market Closed - Nyse Other stock markets 04:00:02 2024-04-18 pm EDT			5-day change	1st Jan Change
69.39 ^USD	+1.15%		-0.50%	-12.12%

Apr. 17	CVS, Cigna, Humana, UnitedHealth - Congress wants to clean up PBMs
Apr. 16	Explainer-Why are US pharmacy benefit managers under fire?	RE

Evolution of the average Target Price on CVS Health Corporation

Price target over the last 5 years

History of analyst recommendation changes

7cce422233ae28.TRyILUrDY2CupKNhp28ejrGgkswGVQsT6JQkUiWXOME.O13gYy6NIi7o6vQZyypS9_6Y5r5OGH54gs5dZk3YFZZ5S-JKA5kLJe3G6g~db660cbee1c2ecc27fac465cfadab1d4

Analyst Recommendations on CVS Health Corporation

Truist Securities Lowers Price Target on CVS Health to $90 From $98, Buy Rating Kept	Apr. 15	MT
CVS' Aetna Better Health of Michigan Gets Recommendation For CHCP Contract	Apr. 09	MT
Wells Fargo Cuts Price Target on CVS Health to $76 From $83, Maintains Equal-Weight Rating	Apr. 08	MT
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors	Apr. 04	RE
Multiple CVS Caremark Plans to Cover Perrigo's Opill at No Cost	Apr. 04	MT
Piper Sandler Adjusts Price Target on CVS Health to $94 From $93, Maintains Overweight Rating	Mar. 15	MT
Leerink Partners Initiates Coverage on CVS Health With Outperform Rating, $88 Price Target	Feb. 26	MT
RBC Trims Price Target on CVS Health to $84 From $86 Amid Cut to 2024 Earnings Guidance, Keeps Outperform Rating	Feb. 08	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
Futures flat with focus on earnings, rate-cut expectations	Feb. 07	RE
Deutsche Bank Adjusts CVS Health Price Target to $77 From $81, Maintains Hold Rating	Feb. 02	MT
US proposes reimbursement rate for Medicare Advantage 2025 payments	Jan. 31	RE
US job data raises doubts about the Fed's next moves	Jan. 05
HSBC Initiates Coverage on CVS Health With Buy Rating, $94 Price Target	Dec. 22	MT
TD Cowen Adjusts Price Target on CVS Health to $99 From $102, Maintains Outperform Rating	Dec. 11	MT
Wall St. mixed after data shows job openings drop	Dec. 05	RE
ANALYST RECOMMENDATIONS : Airbnb, Burberry, Msci, Netflix, Qualcomm...	Nov. 20
ANALYST RECOMMENDATIONS : Best Buy, Diageo, Eli Lilly, Estee Lauder, Home Depot...	Nov. 07
The Fed doesn't want to raise rates (but is pretending to)	Nov. 02
ANALYST RECOMMENDATIONS : Airbnb, Intel, CVS, Caterpillar, Qualcomm...	Nov. 02
RBC Cuts Price Target on CVS Health to $86 From $91, Keeps Outperform Rating	Nov. 02	MT
Wall Street advances as Fed keeps rates steady; Powell sounds less hawkish	Nov. 01	RE
Wall St holds gains as Fed keeps rates steady	Nov. 01	RE
Stock Futures Decline Pre-Bell Ahead of Fed Rate Decision; Europe, Asia Up	Nov. 01	MT
Futures slip as investors await Fed rate verdict	Nov. 01	RE

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

69.39 USD

Average target price

88.46 USD

Spread / Average Target

+27.48%

High Price Target

103 USD

Spread / Highest target

+48.44%

Low Price Target

76 USD

Spread / Lowest Target

+9.53%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CVS Health Corporation

Truist Securities
Wells Fargo Securities
Piper Sandler
Leerink Partners
RBC Capital Markets
Deutsche Bank Securities
HSBC
TD Cowen
Bernstein
Evercore ISI
Wolfe Research
Edward Jones
DA Davidson
Raymond James
Morgan Stanley
UBS
Barclays
Jefferies & Co.
Mizuho Securities
JPMorgan Chase
Goldman Sachs
Cantor Fitzgerald
BofA Securities
Credit Suisse
Loop Capital
Tigress Financial
BMO Capital
Baird
Seaport Global Securities
Guggenheim

Ratings for CVS Health Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar